University of Wisconsin Foundation

In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 13, 2025), University of Wisconsin Foundation reported 7 stock positions worth $137.6 million. Its top holding was Sea Ltd.-ADR (SE) at 23.9% of the portfolio, followed by Pearl Diver Credit Compy (PDCC, 21.6%) and iShares Core S&P 500 ETF (IVV, 20.9%). Compared with Q3 2024, it added to 1 and reduced 4. The biggest buy was 89BIO (ETNB, shares +27%) and the biggest sale Sea Ltd.-ADR (SE, shares −33%).

Most Recent 13F
Q2 2026
Location
MADISON, WI
CIK
0001697228
Portfolio Value
$137.6M (Q4 2024)
SEC Filing
0001697228-25-000001 ↗ filed Feb 13, 2025

Holdings Value

0$50.0M$100.0M$150.0M$200.0M Q1 2024: $88.6M Q1 2024 Q2 2024: $88.8M Q2 2024 Q3 2024: $153.3M Q3 2024 Q4 2024: $137.6M $137.6M Q4 2024 Q1 2025: $117.8M Q1 2025 Q2 2025: $89.4M Q2 2025 Q3 2025: $118.1M Q3 2025 Q4 2025: $118.9M Q4 2025 Q1 2026: $112.6M Q1 2026 Q2 2026: $126.3M Q2 2026

Holdings 7 stocks · $137.6M

SE Sea Ltd.-ADR 23.88% 315,223 $32.9M Reduce -33.1%
PDCC Pearl Diver Credit Compy Inc. 21.64% 1,459,221 $29.8M No change
IVV iShares Core S&P 500 ETF 20.86% 48,753 $28.7M Reduce -14.6%
NU Nu Holdings Ltd./Cayman Isl-A filed as NU HLDGS LTD 10.78% 1,431,951 $14.8M No change
MDGL Madrigal Pharmaceuticals Inc. 9.32% 41,541 $12.8M Reduce -9.2%
AKRO Akero Therapeutics Inc. 8.30% 410,630 $11.4M Reduce -3.1%
ETNB 89BIO Inc. 5.21% 917,357 $7.2M Add +26.7%

Portfolio Sells Q3 2024 → Q4 2024

SE Sea Ltd.-ADR Reduce -33.1% 23.88% −5.09
IVV iShares Core S&P 500 ETF Reduce -14.6% 20.86% −0.61
AKRO Akero Therapeutics Inc. Reduce -3.1% 8.30% +0.37
MDGL Madrigal Pharmaceuticals Inc. Reduce -9.2% 9.32% +2.99

Portfolio Buys Q3 2024 → Q4 2024

ETNB 89BIO Inc. Add +26.7% 5.21% +1.72

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 9$126.3MSMH, CBRS, PDCC, PCVX, NU
Q1 2026 10$112.6MPDCC, NU, PCVX, AAPL, SE
Q4 2025 8$118.9MNU, PDCC, AAPL, NVDA, MSFT
Q3 2025 9$118.1MPDCC, NU, AKRO, RNAM, NVDA
Q2 2025 5$89.4MPDCC, NU, AKRO, MDGL, ETNB
Q1 2025 8$117.8MSE, PDCC, MDGL, NU, AKRO
Q4 2024 7$137.6MSE, PDCC, IVV, NU, MDGL
Q3 2024 7$153.3MSE, IVV, PDCC, NU, AKRO
Q2 2024 6$88.8MIVV, NU, MDGL, GE, AKRO
Q1 2024 6$88.6MIVV, NU, MDGL, GE, AKRO